Injectable codeine is readily available for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this can result in nonimmune mast-cell degranulation and resulting anaphylactoid reaction. Codeine suppositories may also be marketed in a few international locations. In Eire, new rules arrived into effect on 1 August 2010[90] regarding https://www.codeingil.com/